179 results
Page 3 of 9
6-K
EX-99.1
lp6thp5 wq
19 Jan 22
Jyseleca®▼ (Filgotinib) Licensed for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis In Great Britain
11:37am
6-K
EX-99.1
w14si07s
29 Nov 21
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
6:00am
6-K
EX-99.1
94iz 7bciqm3f9f8g6lx
17 Nov 21
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
6:00am
6-K
EX-99.2
nloeqije nz
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.1
nlj0p6g3
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.1
a21s ejc9pu3a3t
6 Oct 21
Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress
6:00am
6-K
EX-99.1
dzcpro
6 Oct 21
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
6:00am
6-K
EX-99.1
xftbo6cr
20 Sep 21
Current report (foreign)
9:26am
6-K
EX-99.1
t13caioniw6
31 Aug 21
Galapagos announces planned retirement of CEO
3:46pm
6-K
EX-99.2
gcywzzk5o4il yj
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
hziqaffxnr
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
xxwywk0k4tw
14 Jul 21
Current report (foreign)
5:27pm
6-K
EX-99.1
laozke2
14 Jul 21
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
5:13pm
6-K
EX-99.1
7fzzeg5wam nbm
12 Jul 21
New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn’s and Colitis Organisation (ECCO) virtual congress
9:02am
6-K
EX-99.1
rs03b
23 Jun 21
Galapagos announces departure of CSO Piet Wigerinck later this year
6:00am
6-K
EX-99.1
vclrmfho vt2
4 Jun 21
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
6:05am
6-K
EX-99.1
k7xjliw
28 May 21
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
6:00am
6-K
EX-99.1
nyg8w v3ypysc2usgd
19 May 21
Current report (foreign)
6:00am
6-K
EX-99.1
lwsi583ipwvi5iq8ib
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.3
9spgs0
11 May 21
Current report (foreign)
2:10pm